Positions

Member
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States
Assistant Professor
Pediatrics
Hematology-Oncology
Baylor College of Medicine
Houston, Texas, United States

Education

BS from Auburn University
Microbiology
MPH from University of Texas Health Science Center
Epidemiology
PhD from University of Texas Health Science Center
Epidemiology
Postdoctoral Fellowship at Baylor College of Medicine
Molecular Epidemiology

Honors & Awards

Delta Omega, Honorary Society in Public Health
Young Investigator Award
Young Investigator Award

Professional Interests

  • Cancer Survivorship
  • Childhood Cancer
  • Cancer Treatment Toxicity
  • Molecular Epidemiology

Selected Publications

Memberships

American Association for Cancer Research (AACR)
American Society of Preventive Oncology (ASPO)
International Society of Paediatric Oncology (SIOP)
American College of Epidemiology (ACE)
Children's Oncology Group

Funding

Pharmacometabolomic Biomarkers of Neuropsychological Outcomes following Pediatric Acute Lymphoblastic Leukemia Therapy
Grant funding from Leukemia Research Foundation
The major goal of this pilot study is to identify novel biomarkers of chemotherapy-induced neurocognitive impairment among pediatric ALL patients.
Genetic Determinants of Neuropsychological Performance Following Treatment for Pediatric Embryonal Brain Tumors
Grant funding from Pablove Foundation
The major goal of this project is to identify genetic modifiers of therapy-related neurocognitive decline in a prospective cohort of pediatric brain tumor patients treated with cranial radiation therapy.
Integrative Molecular Epidemiology of Neurocognitive Outcomes in Acute Lymphoblastic Leukemia
- #K07CA218362
Grant funding from National Cancer Institute
The research objectives of this career development award are to: 1) evaluate the association between patient reported symptoms during childhood leukemia treatment on post-treatment neurocognitive performance, and 2) evaluate potential biomarkers of neurocognitive complications.
Multi-omic Biomarker Discovery for Therapy-related Neurocognitive Impairment in Childhood Acute Lymphoblastic Leukemia
- #RP190132
Grant funding from Cancer Prevention and Research Institute of Texas
The goal of this project is to assemble a overlapping prospective cohorts of childhood leukemia patients and survivors to explore trajectories in neurocognitive performance and evaluate potential drivers of disparities in cognitive outcomes.